LyncBio Therapeutics
Shanghai
About LyncBio Therapeutics
LyncBio Therapeutics is a medical company that provides treatments, research, and toxicology studies about intestinal inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.3M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/lyncbio-therapeutics-69095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.